Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Oncology Reports
Published in: Current Oncology Reports 12/2023

07-12-2023 | Lymphoma | Review

Integrative Approaches in the Treatment of Patients Affected by Lymphoma

Authors: Ilana Levy Yurkovski, Francesca Andreazzoli, Eran Ben-Arye, Samuel Attias, Tamar Tadmor

Published in: Current Oncology Reports | Issue 12/2023

Login to get access

Abstract

Purpose of Review

Lymphoma is the most frequent hematological malignancy with wide disease spectrum of watchful waiting period, active treatment, survivorship, and palliative care. All these steps impose unmet needs in terms of prevention, symptom alleviation, or prognosis. Complementary and integrative medicine (CIM) is widely used by patients with lymphoma to cope with such issues. Here, we describe the different CIM modalities that may be effective and safe for the management of patients with lymphoma.

Recent Findings

Low inflammatory diet and ginseng seem effective for lymphoma prevention. Pain and neuropathy may be improved using acupuncture, touch therapy and specific dietary supplements. Nausea/vomiting, fatigue, and insomnia may be relieved by acupuncture, mind-body, touch therapy, and certain dietary supplements. Vitamin D, curcumin, and some traditional medicine herbs may positively impact lymphoma prognosis. Finally, safety issues should be considered especially for the concomitant use of dietary supplements and lymphoma-directed therapies.

Summary

CIM may be beneficial along the continuum of lymphoma management although safety concerns should be considered when used concomitantly with conventional therapy.
Literature
1.
2.
Liu W, Ji X, Song Y, Wang X, Zheng W, Lin N, et al. Improving survival of 3760 patients with lymphoma: experience of an academic center over two decades. Cancer Med. 2020;9(11):3765–74.PubMedPubMedCentralCrossRef
3.
Konstantinidis TI, Spinthouri M, Ramoutsaki A, Marnelou A, Kritsotakis G, Govina O. Assessment of unmet supportive care needs in haematological cancer survivors. Asian Pacific J Cancer Prev. 2019;20(5):1487–95.CrossRef
4.
Habermann TM, Thompson CA, LaPlant BR, Bauer BA, Janney CA, Clark MM, et al. Complementary and alternative medicine use among long-term lymphoma survivors: A pilot study. Am J Hematol. 2009;84(12):795–8.PubMedPubMedCentralCrossRef
5.
Mahurin HM, Tarabadkar E, Hippe DS, Lachance K, Kim EJ, Loggers ET, et al. Integrative medicine use in patients with cutaneous T-Cell lymphoma: a cross-sectional survey study. Complement Ther Med. 2021;61:102762.PubMedCrossRef
6.
7.
Ben-Arye E, Attias S, Tadmor T, Schiff E. Herbs in hemato-oncological care: an evidence-based review of data on efficacy, safety, and drug interactions. Leuk Lymphoma. 2010;51(8):1414–23.PubMedCrossRef
8.
Afungchwi GM, Hesseling PB, Ladas EJ. The role of traditional healers in the diagnosis and management of Burkitt lymphoma in Cameroon: Understanding the challenges and moving forward. BMC Complement Altern Med. 2017;17(1):1–7.CrossRef
9.
Okolo ON, Gowin K. Emerging role of integrative medicine in hematologic malignancies: a literature review and update on current trends in complementary medical practices in hematologic cancers. Curr Hematol Malig Rep. 2019;14(4):328–36.PubMedCrossRef
10.••
Andreazzoli F, Bonucci M. Integrative hematology: state of the art. Int J Mol Sci. 2023;24(1732):1–23. This review defines the concept of integrative hematology and summarizes the different indications of integrative medicine therapy in patients with hematological malignancy.
11.
Bertrand KA, Giovannucci E, Rosner BA, Zhang SM, Laden F, Birmann BM. Dietary fat intake and risk of non-Hodgkin lymphoma in 2 large prospective cohorts. Am J Clin Nutr. 2017;106(2):650–6.PubMedPubMedCentralCrossRef
12.
Solimini AG, Lombardi AM, Palazzo C, De Giusti M. Meat intake and non-Hodgkin lymphoma: a meta-analysis of observational studies. Cancer Causes Control. 2016;27(5):595–606.PubMedCrossRef
13.
Shivappa N, Hébert JR, Taborelli M, Montella M, Libra M, Zucchetto A, et al. Dietary inflammatory index and non-Hodgkin lymphoma risk in an Italian case–control study. Cancer Causes Control. 2017;28(7):791–9.PubMedPubMedCentralCrossRef
14.
Solans M, Benavente Y, Saez M, Agudo A, Jakszyn P, Naudin S, et al. Inflammatory potential of diet and risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition. Eur J Nutr. 2020;59(2):813–23.PubMedCrossRef
15.•
Saberi Hosnijeh F, Casabonne D, Nieters A, Solans M, Naudin S, Ferrari P, et al. Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis. Int J Cancer. 2021;148(9):2115–28. This paper summarizes possible factors impacting the incidence of B-cell lymphoma using an exposome-wide analysis of a large population.PubMedCrossRef
16.
Solans M, Benavente Y, Saez M, Agudo A, Naudin S, Hosnijeh FS, et al. Adherence to the mediterranean diet and lymphoma risk in the european prospective investigation into cancer and nutrition. Int J Cancer. 2019;145(1):122–31.PubMedCrossRef
17.
Almanza-Aguilera E, Cano A, Gil-Lespinard M, Burguera N, Zamora-Ros R, Agudo A, et al. Mediterranean diet and olive oil, microbiota, and obesity-related cancers. From mechanisms to prevention. Semin Cancer Biol. 2023;95:103–19.PubMedCrossRef
18.
Pradhan P, Wen W, Cai H, Gao YT, Shu X, ou, Zheng W. Prospective cohort study of ginseng consumption in association with cancer risk: Shanghai Women’s Health Study. J Nutr. 2023;153(4):1170–7.PubMedCrossRef
19.
Kelly JL, Friedberg JW, Calvi LM, Van Wijngaarden E, Fisher SG. Vitamin D and non-hodgkin lymphoma risk in adults: a review. Cancer Invest. 2009;27(9):942–51.PubMedPubMedCentralCrossRef
20.
Psaltopoulou T, Ntanasis-Stathopoulos I, Tsilimigras DI, Tzanninis IG, Gavriatopoulou M, Sergentanis TN. Micronutrient Intake and Risk of Hematological Malignancies in Adults: A Systematic Review and Meta-analysis of Cohort Studies. Nutr Cancer. 2018;70(6):821–39.PubMedCrossRef
21.
22.••
Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, et al. Integrative medicine for pain management in oncology: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol. 2022;40(34):3998–4024. This guideline paper summarizes the collaboration effort between the Society for Integrative Oncology and ASCO and their recommendations for the treatment of pain in patients with cancer.PubMedCrossRef
23.••
El Iskandarani S, Deng G. Acupuncture in hematologic malignancies and hematopoietic cell transplantation. Blood Rev. 2022;56:100985. This shows the positive effects of acupuncture on patients undergoing hematopoietic cell transplantation, mainly for reducing pain, nausea and vomiting, but also for the alleviation of CIPN, fatigue, sleep disorders, night sweat and pruritus.PubMedPubMedCentralCrossRef
24.
Tabatabaee A, Tafreshi MZ, Rassouli M, Aledavood SA, AlaviMajd H, Farahmand SK. Effect of therapeutic touch in patients with cancer: a literature review. Med Arch. 2016;70(2):142–7.PubMedPubMedCentralCrossRef
25.
Rambod M, Pasyar N, Shamsadini M. The effect of foot reflexology on fatigue, pain, and sleep quality in lymphoma patients: A clinical trial. Eur J Oncol Nurs. 2019;43:101678.PubMedCrossRef
26.
Stephenson NLN, Swanson M, Dalton JA, Keefe FJ, Engelke M. Partner-delivered reflexology: Effects on cancer pain and anxiety. Oncol Nurs Forum. 2007;34(1):127–32.PubMedCrossRef
27.
Zhang Y, Wang S, Ma X, Yuan Y, Cheng H, Lin L, et al. Massage therapy can effectively relieve cancer pain: a meta-analysis. Medicine (Baltimore). 2023;102(27):e33939.PubMedPubMedCentralCrossRef
28.
29.
Ghirardi O, Lo Giudice P, Pisano C, Vertechy M, Bellucci A, Vesci L, et al. Acetyl-L-carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties. Anticancer Res. 2005;25(4):2681–8.PubMed
30.
Abad ANA, Nouri MHK, Tavakkoli F. Effect of Matricaria chamomilla hydroalcoholic extract on cisplatin-induced neuropathy in mice. Chin J Nat Med. 2011;9(2):125–31.
31.
Abad ANA, Nouri MHK, Tavakkoli F. Effect of Salvia officinalis hydroalcoholic extract on vincristine-induced neuropathy in mice. Chin J Nat Med. 2011;9(5):354–8.
32.
Sands S, Ladas EJ, Kelly KM, Weiner M, Lin M, Ndao DH, et al. Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer. Support Care Cancer. 2017;25(3):701–8.PubMedCrossRef
33.
Schloss JM, Colosimo M, Airey C, Masci P, Linnane AW, Vitetta L. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Support Care Cancer. 2017;25(1):195–204.PubMedCrossRef
34.
Sarisoy P, Ovayolu O. The effect of foot massage on peripheral neuropathy-related pain and sleep quality in patients with non-Hodgkin’s lymphoma. Holist Nurs Pract. 2020;34(6):345–55.PubMedCrossRef
35.
Kutcher AM, LeBaron VT. Evaluating acupuncture for the treatment of chemotherapy-induced peripheral neuropathy: an integrative review. West J Nurs Res. 2022;44(2):169–79.PubMedCrossRef
36.••
Ben-Arye E, Hausner D, Samuels N, Gamus D, Lavie O, Tadmor T, et al. Impact of acupuncture and integrative therapies on chemotherapy-induced peripheral neuropathy: a multicentered, randomized controlled trial. Cancer. 2022; This RCT summarizes the positive effect of acupuncture and other CIM modalities on QoL in patients with CIPN. This is the first study to evaluate the combination of acupuncture with other CIM modalities on CIPN.
37.
Gupta K, Walton R, Kataria SP. Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends. Cancer Treat Res Commun. 2021;26:100278.PubMedCrossRef
38.
Mora DC, Overvåg G, Jong MC, Kristoffersen AE, Stavleu DC, Liu J, et al. Complementary and alternative medicine modalities used to treat adverse effects of anti-cancer treatment among children and young adults: a systematic review and meta-analysis of randomized controlled trials. BMC Complement Med Ther. 2022;22(1):1–21.CrossRef
39.
Li DH, Su YF, Fan HF, Guo N, Sun CX. Acupuncture combined with three-step analgesic drug therapy for treatment of cancer pain: a systematic review and meta-analysis of randomised clinical trials. Evidence-based Complement Altern Med. 2021;2021 https://​doi.​org/​10.​1155/​2021/​5558590.
40.•
Choi J, Lee J, Kim K, Choi HK, Lee SA, Lee HJ. Effects of ginger intake on chemotherapy-induced nausea and vomiting: a systematic review of randomized clinical trials. Nutrients. 2022;14(23):1–17. This shows the positivie effects of ginger in the treatment of CINVCrossRef
41.
Alparslan GB, Ozkarman A, Eskin N, Yilmaz S, Akay M, Acikgoz A, et al. Effect of ginger on chemotherapy-induced nausea and/or vomiting in cancer patients. J Aust Tradit Med Soc. 2012;18(1):15–8.
42.
Marx W, McCarthy AL, Ried K, McKavanagh D, Vitetta L, Sali A, et al. The effect of a standardized ginger extract on chemotherapy-induced nausea-related quality of life in patients undergoing moderately or highly emetogenic chemotherapy: a double blind, randomized, placebo controlled trial. Nutrients. 2017;9(8)
43.
Marx W, Ried K, McCarthy AL, Vitetta L, Sali A, McKavanagh D, et al. Ginger—Mechanism of action in chemotherapy-induced nausea and vomiting: a review. Crit Rev Food Sci Nutr. 2017;57(1):141–6.PubMedCrossRef
44.
Wang XS, Giralt SA, Mendoza TR, Engstrom MC, Johnson BA, Peterson N, et al. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin’s lymphoma. J Clin Oncol. 2002;20(5):1319–28.PubMed
45.
Shan S, Lin L, Fang Q, Tian F, Guo D, Zhou Y, et al. Massage therapy significantly improves cancer-related fatigue in cancer patients: a meta-analysis of randomized controlled trials. Support Care Cancer. 2023;31(8):464.PubMedCrossRef
46.
Yeh ML, Chung YC. A randomized controlled trial of qigong on fatigue and sleep quality for non-Hodgkin’s lymphoma patients undergoing chemotherapy. Eur J Oncol Nurs. 2016;23:81–6.PubMedCrossRef
47.
Kaur G, Prakash G, Malhotra P, Ghai S, Kaur S, Singh M, et al. Home-Based yoga program for the patients suffering from malignant lymphoma during chemotherapy: a feasibility study. Int J Yoga. 2018;11(3):249.PubMedPubMedCentralCrossRef
48.
49.
Zhang Y, Lin L, Li H, Hu Y, Tian L. Effects of acupuncture on cancer-related fatigue: a meta-analysis. Support Care Cancer. 2018;26:415–25.PubMedCrossRef
50.
Chang YD, Smith J, Portman D, Kim R, Oberoi-Jassal R, Rajasekhara S, et al. single institute experience with methylphenidate and American ginseng in cancer-related fatigue. Am J Hosp Palliat Med. 2018;35(1):144–50.CrossRef
51.
Lemke EA. Ginseng for the management of cancer-related fatigue: an integrative review. J Adv Pract Oncol. 2021;12(4)
52.
Amatya B, Khan F, Lew TE, Dickinson M. Rehabilitation in patients with lymphoma: an overview of systematic reviews. J Rehabil Med. 2021;53(3):jrm00163.PubMedCrossRef
53.
Cohen L, Warneke C, Fouladi RT, Rodriguez MA, Chaoul-Reich A. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer. 2004;100(10):2253–60.PubMedCrossRef
54.
Felbel S, Meerpohl JJ, Monsef I, Engert A, Skoetz N. Yoga in addition to standard care for patients with haematological malignancies. Cochrane Database Syst Rev. 2014;2014(6)
55.••
Nagata A, Kanemasa Y, Sasaki Y, Nakamura S, Okuya T, Funasaka C, et al. Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B-cell lymphoma. Hematol Oncol. 2020;38(3):309–17. The positive effects of a low inflammatory diet in patients with DLBCL are summarized in this articlePubMedCrossRef
56.
Matsukawa T, Suto K, Kanaya M, Izumiyama K, Minauchi K, Yoshida S, et al. Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma. Ann Hematol. 2020;99(12):2859–68.PubMedCrossRef
57.
Baysal M, Bas V, Demirci U, Gulsaran S, Umit E, Kirkizlar H, et al. The utility of CONUT score in diffuse large B cell lymphoma patients. Niger J Clin Pract. 2021;24(8):1194–9.PubMedCrossRef
58.
59.
Wu W, Ren K, Chen X, Li N, Zhou H, Jiang M, et al. A controlling nutritional status score is an independent predictor for patients with newly diagnosed nasal-type extranodal NK/T-cell lymphoma based on asparaginase-containing regimens. Cancer Med. 2023;12(8):9439–48.PubMedPubMedCentralCrossRef
60.
Atas U, Sozel H, Iltar U, Yucel OK, Salim O, Undar L. The prognostic impact of pretreatment geriatric nutritional risk index in patients with diffuse large B-cell lymphoma. Nutr Cancer. 2023;75(2):591–8.PubMedCrossRef
61.
Zhang Y, Chen Q, Lu C, Yu L. Prognostic role of controlling nutritional status score in hematological malignancies. Hematology. 2022;27(1):653–8.PubMedCrossRef
62.•
Ma Y, Lu X, Liu H. Neutropenic diet cannot reduce the risk of infection and mortality in oncology patients with neutropenia. Front. Oncol. 2022;12:1–8. This study shows that the well recognized "neutropenic diet" administered to patients with neutropenia seems not to actually impact prognosis, and therefore should not be recommended
63.•
Tao Y, Chen H, Zhou Y, Shi Y. Meta-analysis of the prognostic and clinical value of serum 25-hydroxyvitamin D levels in previously untreated lymphoma. Futur Oncol. 2021;17(14):1825–38. This meta-analysis shows that low level of vitamin D in patients with previously untreated lymphoma is associated with worse outcomesCrossRef
64.
Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control. 2012;23(2):363–70.PubMedCrossRef
65.
Borchmann S, Cirillo M, Goergen H, Meder L, Sasse S, Kreissl S, et al. Pretreatment Vitamin D deficiency is associated with impaired progression-free and overall survival in hodgkin lymphoma. J Clin Oncol. 2019;37(36):3528–37.PubMedCrossRef
66.
Drake MT, Maurer MJ, Link BK, Habermann TM, Ansell SM, Micallef IN, et al. Vitamin D insufficiency and prognosis in non-Hodgkin’s lymphoma. J Clin Oncol. 2010;28(27):4191–8.PubMedPubMedCentralCrossRef
67.
Kelly JL, Salles G, Goldman B, Fisher RI, Brice P, Press O, et al. Low serum vitamin D levels are associated with inferior survival in follicular lymphoma: a prospective evaluation in SWOG and LYSA studies. J Clin Oncol. 2015;33(13):1482–90.PubMedPubMedCentralCrossRef
68.
Hutchinson K, Jahangiri S, Calvi LM, Barr P, Friedberg JW, Kelly JL. Impact of dietary supplements, obesity and treatment initiation on serum vitamin D levels in patients with lymphoma. Leuk Lymphoma. 2015;56(2):508–11.PubMedCrossRef
69.•
Nath K, Tomas AA, Flynn J, Fein JA, Alperovich A, Anagnostou T, et al. Vitamin D insufficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in large B-cell lymphoma. Transplant Cell Ther. 2022;28(11):751.e1–7. This study shows that patients with vitamin D insufficiency undergoing CAR-T cell therapy for the treatment of DLBCL have worse treatment-related prognosisPubMedCrossRef
70.•
Jiménez-Cortegana C, Sánchez-Martínez PM, Palazón-Carrión N, Nogales-Fernández E, Henao-Carrasco F, García-Sancho AM, et al. Lower survival and increased circulating suppressor cells in patients with relapsed/refractory diffuse large B-cell lymphoma with deficit of vitamin D levels using R-GDP plus lenalidomide (R2-GDP): Results from the R2-GDP-gotel trial. Cancers (Basel). 2021;13(18) This study shows that patients with vitamin D deficiency undergoing R2-GDP therapy for the treatment of R/R DLBCL have worse prognosis
71.
Hohaus S, Tisi MC, Bellesi S, Maiolo E, Alma E, Tartaglia G, et al. Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy. Cancer Med. 2018;7(1):270–81.PubMedCrossRef
72.
Bruns H, Büttner M, Fabri M, Mougiakakos D, Bittenbring JT, Hoffmann MH, et al. Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphoma. Sci Transl Med. 2015;7(282):3230.CrossRef
73.
Kulling PM, Olson KC, Olson TL, Feith DJ, Loughran TP. Vitamin D in hematological disorders and malignancies. Eur J Haematol. 2017;98(3):187–97.PubMedCrossRef
74.
Talib WH, AlHur MJ, Al Naimat S, Ahmad RE, Al-Yasari AH, Al-Dalaeen A, et al. Anticancer effect of spices used in Mediterranean diet: preventive and therapeutic potentials. Front Nutr. 2022;9:1–15.CrossRef
75.
Tan BL, Norhaizan ME. Curcumin combination chemotherapy: the implication and efficacy in cancer. Molecules. 2019;24(14):1–21.CrossRef
76.
Zhang W, Li Q, Yang C, Yang H, Rao J, Zhang X. Curcumin exerts anti-tumor effects on diffuse large B cell lymphoma via regulating PPARγ expression. Biochem Biophys Res Commun. 2020;524(1):70–6.PubMedCrossRef
77.
Zhang Y, Xiang J, Zhu N, Ge H, Sheng X, Deng S, et al. Curcumin in combination with omacetaxine suppress lymphoma cell growth, migration, invasion, and angiogenesis via inhibition of VEGF/Akt signaling pathway. Front Oncol. 2021;11:1–13.
78.
Li XX, Liu C, Dong SL, Ou CS, Lu JL, Ye JH, et al. Anticarcinogenic potentials of tea catechins. Front Nutr. 2022;9:1–24.CrossRef
79.
Shanafelt TD, Call TG, Zent CS, LaPlant B, Bowen DA, Roos M, et al. Phase I trial of daily oral polyphenon E in patients with asymptomatic rai stage 0 to II chronic lymphocytic leukemia. J Clin Oncol. 2009;27(23):3808–14.PubMedPubMedCentralCrossRef
80.
Shanafelt TD, Call TG, Zent CS, Leis JF, Laplant B, Bowen DA, et al. Phase 2 trial of daily, oral polyphenon e in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Cancer. 2013;119(2):363–70.PubMedCrossRef
81.
82.
Lee S, Jeon H, Park S, Lee S, Chang HJ, Eo W. A potential treatment option for elderly non-Hodgkin lymphoma patients with multiple comorbidities: two case reports and literature review. Explore. 2021;17(3):265–9.PubMedCrossRef
83.
Liang H, Guo J, Li CG. Long-term complete remission of a patient with double-hit diffuse large B-cell lymphoma treated by chemoimmunotherapy and Chinese herbal medicine. Integr Cancer Ther. 2023;22:1–7.CrossRef
84.
Kumagai T, Müller CI, Desmond JC, Imai Y, Heber D, Koeffler HP. Scutellaria baicalensis, a herbal medicine: anti-proliferative and apoptotic activity against acute lymphocytic leukemia, lymphoma and myeloma cell lines. Leuk Res. 2007;31(4):523–30.PubMedCrossRef
85.
Wang H, Wang F, Wu S, Liu Z, Li T, Mao L, et al. Traditional herbal medicine-derived sulforaphene promotes mitophagic cell death in lymphoma cells through CRM1-mediated p62/SQSTM1 accumulation and AMPK activation. Chem Biol Interact. 2018;281:11–23.PubMedCrossRef
86.
Jang DK, Lee IS, Shin HS, Yoo HM. 2alpha-Hydroxyeudesma-4,11(13)-Dien-8Β,12-olide isolated from Inula britannica induces apoptosis in diffuse large B-cell lymphoma cells. Biomolecules. 2020;10(2)
87.
Yang S, Evens AM, Prachand S, Singh AT, Bhalla S, David K, et al. Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone Andrographolide, the active component of Andrographis paniculata. Clin Cancer Res2. 2010;16(19):4755–68.CrossRef
88.
Huang Q, Lin J, Huang S, Shen J. Impact of Qi-invigorating traditional Chinese medicines on diffuse large B cell lymphoma based on network pharmacology and experimental validation. Front Pharmacol. 2021;12:1–21.CrossRef
89.
Wu T, Wang S, Wu J, Lin Z, Sui X, Xu X, et al. Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma. J Exp Clin Cancer Res. 2015;34(1):1–11.CrossRef
90.
Ni F, Huang X, Chen Z, Qian W, Tong X. Shikonin exerts antitumor activity in Burkitt’s lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin. Sci Rep. 2018;8(1):1–10.CrossRef
91.
Li W, Lv L, Ruan M, Xu J, Zhu W, Li Q, et al. Qin Huang formula enhances the effect of Adriamycin in B-cell lymphoma via increasing tumor infiltrating lymphocytes by targeting toll-like receptor signaling pathway. BMC Complement Med Ther. 2022;22(1):1–16.CrossRef
92.
Sato T, Kita K, Sato C, Kaneda A. Hochu-ekki-to (Bu-zhong-yi-qi-tang), a herbal medicine, enhances cisplatin-induced apoptosis in HeLa cells. Mol Med Rep. 2015;12(4):6215–20.PubMedCrossRef
93.
Chen KW, Shiflett SC, Ponzio NM, He B, Elliott DK, Keller SE. A preliminary study of the effect of external Qigong on lymphoma growth in mice. J Altern Complement Med. 2002;8(5):615–21.PubMedCrossRef
94.
Hamilton AS, Miller MF, Arora NK, Bellizzi KM, Rowland JH. Predictors of use of complementary and alternative medicine by non-Hodgkin lymphoma survivors and relationship to quality of life. Integr Cancer Ther. 2013;12(3):225–35.PubMedCrossRef
95.
96.•
Vargas-Román K, De la Fuente-Solana EI, Cortés-Martín J, Sánchez-García JC, González-Vargas CJ, Díaz-Rodríguez L. Effect of a 16-Session Qigong Program in non-Hodgkin lymphoma survivors: a randomized clinical trial. J Clin Med. 2022;11(12) This RCT showed that qigong improves QoL in NHL survivors
97.
Hathiramani S, Pettengell R, Moir H, Younis A. Relaxation versus exercise for improved quality of life in lymphoma survivors—a randomised controlled trial. J Cancer Surviv. 2021;15(3):470–80.PubMedCrossRef
98.•
Weinhold KR, Light S, Bittoni AM, Zick S, Orchard TS. A remote Whole food dietary intervention to reduce fatigue and improve diet quality in lymphoma survivors: results of a feasibility pilot study. Nutr Cancer. 2023;75(3):937–47. https://​doi.​org/​10.​1080/​01635581.​2023.​2173259. This pilot study shows that a "whole food" diet seems to reduce fatigue in lymphoma survivors.CrossRefPubMed
99.
Hübner J, Beckmann M, Follmann M, Nothacker M, Prott FJ, Wörmann B. Complementary medicine in the treatment of cancer patients. Dtsch Arztebl Int. 2021;118(39):654–9.PubMedPubMedCentral
100.
Frenkel M, Sierpina V, Sapire K. Effects of complementary and integrative medicine on cancer survivorship. Curr Oncol Rep. 2015;17(21):1–13.
101.••
Kayo T, Suzuki M, Mitsuma T, Suzuki M, Ikeda S, Sukegawa M, et al. Bleeding risk of acupuncture for patients with hematological malignancies accompanying thrombocytopenia: a retrospective chart review. J Integr Complement Med. 2023:1–8. This study shows the safety of acupuncture including among patients with severe thrombocytopenia
102.
Fancher KM, Pappacena JJ. Drug interactions with Bruton’s tyrosine kinase inhibitors: clinical implications and management. Cancer Chemother Pharmacol. 2020;86(4):507–15.PubMedCrossRef
103.
Satoh T, Fujisawa H, Nakamura A, Takahashi N, Watanabe K. Inhibitory effects of eight green tea catechins on cytochrome P450 1A2, 2C9, 2D6, and 3A4 activities. J Pharm Pharm Sci. 2016;19(2):188–97.PubMedCrossRef
104.••
Samuels N, Ben-Arye E. Exploring herbal medicine use during palliative cancer care: the integrative physician as a facilitator of pharmacist–patient–oncologist communication. Pharmaceuticals. 2020;13(12):1–14. This article shows the importance of the integrative physician in the management of patients with cancerCrossRef
Metadata
Title
Integrative Approaches in the Treatment of Patients Affected by Lymphoma
Authors
Ilana Levy Yurkovski
Francesca Andreazzoli
Eran Ben-Arye
Samuel Attias
Tamar Tadmor
Publication date
07-12-2023
Publisher
Springer US
Published in
Current Oncology Reports / Issue 12/2023
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-023-01476-4

Other articles of this Issue 12/2023

Current Oncology Reports 12/2023 Go to the issue

REVIEW

Postmastectomy functional impairments

REVIEW

Limb amputations in cancer

ReviewPaper

Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan

ReviewPaper

Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis

Correction

Correction to: Postmastectomy Functional Impairments

ReviewPaper

Shifting Strategies in the Treatment of Pediatric Craniopharyngioma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits